MRC2 and breast carcinoma: This differentiates it from other cancers where uPARAP/Endo180 can be produced by the cancer cells themselves and is the case in sarcomas such as osteosarcoma [35], some glioblastoma subsets [77] and triple-negative basal-like breast cancers [78].